GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Additional Paid-In Capital

Nortem Biogroup (XPAR:MLBIO) Additional Paid-In Capital : €0.00 Mil(As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Additional Paid-In Capital?



Nortem Biogroup Additional Paid-In Capital Historical Data

The historical data trend for Nortem Biogroup's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Additional Paid-In Capital Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Additional Paid-In Capital
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Additional Paid-In Capital - -

Nortem Biogroup Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Nortem Biogroup Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines